A meningococcal group C conjugate vaccine was introduced into the routine schedule in the UK
In 1999, a meningococcal group C conjugate vaccine was introduced into the routine schedule in the U.K. for…
In 1999, a meningococcal group C conjugate vaccine was introduced into the routine schedule in the U.K. for…
In 1999, the Vancouver Prostate Centre received a $20 million donation by Vancouver businessman Jim Pattison, the largest…
In 1999, Michael Smith, recipient of the 1993 Nobel Prize in Chemistry, founded Canada’s Michael Smith Genome Science…
In 1999, University of California at San Francisco Cancer Research Institute received NCI Comprehensive Cancer Center designation. The…
On Oct. 30, 1999, Livermore National Lab work completed work on the mouse genome as part of Laboratory…
In 1999, Dr. Emil Kakkis at Los Angeles Biomedical Research Institute (LA BioMed) developed Enzyme Replacement Therapy to…
In 1999, the Del E. Webb Center for Neuroscience and Aging, which focuses on diseases such as stroke,…
In 1999, the Delaware Biotechnology Institute was founded as a partnership among government, academia and industry to help…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) launched the National Pharmaceutical Stockpile, now the…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) established the Laboratory Response Network (LRN). The…
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
On Dec. 22, 1998, Washington University – St. Louis researcher Jeffrey I. Gordon, MD and colleagues developed a…
Dec. 22, 1998, researchers from Barnes-Jewish Hospital in St. Louis announced using a revolutionary system that uses superconducting…
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
On Nov. 23, 1998, The University of California, Berkeley and the Novartis Agricultural Discovery Institute announced that they…
On Nov. 3, 1998, the NASDAQ completed its merger with the American Stock Exchange, which mostly traded options…
On Oct. 30, 1998, Peter Eriksson of the Salk Institute and Fred Gage of the Sahlgrenska University Hospital…
On Oct. 13, 1998, the Nobel Prize in Chemistry was divided equally between Walter Kohn “for his development…
On Oct. 12, 1998, Louis J. Ignarro of the University of California School of Medicine was awarded the…
On Oct. 8, 1998, a team from Kinki University reported the first successful cloning of adult cows. To…
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
On Sept. 8, 1998, the Medical College of Georgia researchers Dr. David Munn and immunologist Andrew Melllor identified…
On Aug. 31, 1998, Rotashield (Wyeth Laboratories, Marietta, Pennsylvania) was licensed by the U.S. Food and Drug Administration…
On Aug. 26, 1998, the Children’s Vaccine Program was established at WHO’s Program for Appropriate Technology in Health…
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
On Jul. 29, 1998, the diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Certiva by North American…
On Jul. 15, 1998, Aptein, founded by Glenn Kawasaki in Seattle, was acquired by Cambridge Antibody Technology (CAT)…
In 1998, Rainbow papaya seed, a transgenic virus-resistant variety, were released to farmers, allowing farmers to cultivate this…
On Jun. 16, 1998, University of Washington Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s announced the…